Back
Calvert US Mid-Cap Core Responsible Index ETF Vs. Monopar Therapeutics, Inc. Industry Stock Comparison
Buy
54
CVMC
Calvert US Mid-Cap Core Responsible Index ETF
Last Price:
$65.72
Seasonality Move:
2.92%
Sell
39
MNPR
Monopar Therapeutics, Inc.
Last Price:
$74.46
Seasonality Move:
36.18%
Buy
54
Calvert US Mid-Cap Core Responsible Index ETF (CVMC)
is a Buy
Is Calvert US Mid-Cap Core Responsible Index ETF a Buy, Sell or Hold?
-
The current Calvert US Mid-Cap Core Responsible Index ETF [CVMC] share price is $65.00. The Score for CVMC is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
-
CVMC is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
39
Monopar Therapeutics, Inc. (MNPR)
is a Sell
Is Monopar Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Monopar Therapeutics, Inc. [MNPR] share price is $74.61. The Score for MNPR is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
-
MNPR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CVMC Stock Price Chart
What is Calvert US Mid-Cap Core Responsible Index ETF's stock price today?
-
The Calvert US Mid-Cap Core Responsible Index ETF share price today is $65.00Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CVMC is experiencing selling pressure, which indicates risk of future bearish movement.
MNPR Stock Price Chart
What is Monopar Therapeutics, Inc.'s stock price today?
-
The Monopar Therapeutics, Inc. share price today is $74.61Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MNPR is experiencing slight selling pressure.
CVMC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.53 | Buy |
| Relative Strength Index (14 RSI): | 58.57 | Buy |
| Chaikin Money Flow: | -2565 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (62.4 - 64.76) | Buy |
| Bollinger Bands (100): | (62.19 - 64.07) | Buy |
MNPR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.71 | Sell |
| Relative Strength Index (14 RSI): | 41.23 | Sell |
| Chaikin Money Flow: | -100149 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (76.75 - 86.63) | Sell |
| Bollinger Bands (100): | (43.73 - 88.49) | Buy |
CVMC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 64.7 | Buy |
| 20-day SMA: | 63.59 | Buy |
| 50-day SMA: | 63.46 | Buy |
| 200-day SMA: | 60.59 | Buy |
| 8-day EMA: | 64.72 | Buy |
| 20-day EMA: | 64.08 | Buy |
| 50-day EMA: | 63.54 | Buy |
| 200-day EMA: | 61.63 | Buy |
MNPR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 77.35 | Sell |
| 20-day SMA: | 81.26 | Sell |
| 50-day SMA: | 84.43 | Sell |
| 200-day SMA: | 51.38 | Buy |
| 8-day EMA: | 77.66 | Sell |
| 20-day EMA: | 80.1 | Sell |
| 50-day EMA: | 78.38 | Sell |
| 200-day EMA: | 56.01 | Buy |
Calvert US Mid-Cap Core Responsible Index ETF Earnings Growth & CVMC Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Monopar Therapeutics, Inc. Earnings Growth & MNPR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.58 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and a decrease next year of $1.78 per share.
Calvert US Mid-Cap Core Responsible Index ETF Technical Analysis
| Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Monopar Therapeutics, Inc. Technical Analysis
| Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||